Welcome to The Center for Data-Driven Discovery in Biomedicine
Breakthroughs for every child, every time, everywhere
Which Best Describes Yourself?
-
Explorer -
Government -
Healthcare -
Partners -
Patients -
Research
Explorer
Learn more about the research initiatives and breakthroughs happening every day throughout The Center for Data Driven Discovery in Biomedicine. The center brings together leading clinical care professionals, data scientists, bioinformaticians and other researchers to discover cures and better therapeutics for children diagnosed with cancer and other diseases.
-
Explorer
Chordoma Foundation Biobank
Background The Chordoma Foundation (CF) biospecimens, clinical and genomic data via the expertise and tools created by the Center for Data Driven Discovery (D3b) at the Children’s Hospital…
-
Explorer
Oligo Nation
Oligodendroglioma Oligodendroglioma (Oligo) is a primary malignant brain cancer that develops from Oligodendrocytes. Oligodendroglioma is one of the more common types of glioma (which also includes Glioblastoma Multiforme…
-
Explorer
Pario Group – Congenital Birth Defect Biobanking for Genetic Research
Pario Group is a genetic research effort to store samples from cohorts of congenital birth defects in children in order to improve doctors’ abilities to assess the long-term…
-
Explorer
Cole-Reagins Registry for Sinonasal Cancer (CORSICA)
About CORSICA Funded by the Cole-Reagins Family Foundation after the death of a family member from sinus cancer, the Cole-Reagins Registry for Sinonasal Cancer (CORSICA) is a Stanford…
-
Explorer
The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system
Abstract PURPOSE: Clinicians and researchers must contextualize a patient’s genetic variants against population-based references with detailed phenotyping. We sought to establish globally scalable technology, policy, and procedures for…
-
Explorer
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models
Abstract Alpha-emitters can be pharmacologically delivered for irradiation of single cancer cells, but cellular lethality could be further enhanced by targeting alpha-emitters directly to the nucleus. PARP-1 is…
